Oropharyngeal cancer mainly refers to malignant tumors occurring in the oropharyngeal region, with squamous cell carcinoma being the most common type. It is more common in middle-aged and elderly men, with smoking, alcohol consumption, and human papillomavirus (HPV) infection as major risk factors. In recent years, with lifestyle changes and the rising rate of HPV infections, the incidence of oropharyngeal cancer has gradually increased.
The incidence of oropharyngeal cancer varies across regions worldwide. In Southeast Asia, due to high tobacco and alcohol consumption, the incidence rate is higher. In Western countries, HPV infection has become the main causative factor, leading to an increasing incidence of oropharyngeal cancer.
1. Difficulty swallowing
Patients with oropharyngeal cancer often experience difficulty swallowing, which affects normal eating and leads to malnutrition and weight loss.
2. Speech disorders
When the tumor invades the tongue base, soft palate, or other areas, it may cause unclear speech and affect communication.
3. Restricted breathing
In advanced cases, tumor enlargement may compress the airway, causing breathing difficulties and even suffocation.
4. Psychological stress
The treatment process of oropharyngeal cancer is long, and patients often suffer from anxiety, depression, and other psychological issues, affecting their quality of life.
Immune reconstruction cell therapy is an emerging treatment method that activates the patient's own immune system to recognize and kill cancer cells. This therapy has advantages such as fewer side effects and strong targeting ability, and it has shown good efficacy in various cancers.
In actual treatment, cancer patients undergoing surgery, radiotherapy, and chemotherapy often face problems such as impaired immune function, increased infection risk, and slow recovery. To help patients better cope with treatment, improve tolerance, and enhance survival quality, it is necessary to scientifically formulate phased immune reconstruction plans for different treatment cycles.
● Short-term plan: Rapidly enhance immunity through immune cell transfusion to improve the effectiveness of anti-tumor treatment.
● Mid-term plan: Reduce side effects of conventional treatments, promote physical recovery, and ensure completion of standard treatment courses.
● Long-term plan: Comprehensively improve immunity through immune cell reconstruction, intestinal immune reconstruction, elemental immune reconstruction, and immune nutrition reconstruction, thereby improving quality of life and extending survival.
1. Surgical treatment
Surgery is the main treatment for early-stage oropharyngeal cancer, aiming to remove the tumor tissue and restore oropharyngeal function. For advanced cases, surgery may need to be combined with other treatments.
2. Radiotherapy
Radiotherapy is suitable for patients who cannot undergo surgery or as adjuvant treatment after surgery. It uses high-energy rays to kill cancer cells and control tumor growth.
3. Chemotherapy
Chemotherapy is often combined with radiotherapy to enhance efficacy. For advanced or metastatic oropharyngeal cancer, chemotherapy is an important treatment option.
4. Targeted therapy
Targeted therapy uses specific drugs to act on particular molecules of cancer cells, reducing damage to normal cells and improving treatment precision.
5. Minimally invasive treatment
With advances in medical technology, minimally invasive surgery is increasingly applied in oropharyngeal cancer treatment, offering advantages such as less trauma and faster recovery.
Oropharyngeal cancer is a malignant tumor with significant harm. Its early symptoms are not obvious and are easily overlooked. Through the combined application of various treatments, including immune reconstruction cell therapy, treatment efficacy can be improved and patients' quality of life enhanced. Experts from the United Life International Medical Center suggest that the public should increase awareness of oropharyngeal cancer, undergo regular oral examinations, and ensure early detection and early treatment.